Refining existing knowledge and management of bladder cancer

被引：4

作者：

Teo, Min Yuen ^{[1
]}

Rosenberg, Jonathan E. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, Div Solid Tumor Oncol, 1275 York Ave, New York, NY 10021 USA

来源：

NATURE REVIEWS UROLOGY | 2019年 / 16卷 / 02期

关键词：

OPEN-LABEL; PHASE-3;

D O I：

10.1038/s41585-018-0137-3

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

For the management of bladder cancer, 2018 has been characterized by deepened knowledge on the molecular basis of invasive bladder cancer and its potential interaction with existing therapies, optimization of the use of immune checkpoint inhibitors, and emerging early signals on new therapeutic classes for advanced disease.

引用

页码：75 / 76

页数：2

共 10 条

[1] Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma [J].

Bellmunt, J. ;

de Wit, R. ;

Vaughn, D. J. ;

Fradet, Y. ;

Lee, J. -L. ;

Fong, L. ;

Vogelzang, N. J. ;

Climent, M. A. ;

Petrylak, D. P. ;

Choueiri, T. K. ;

Necchi, A. ;

Gerritsen, W. ;

Gurney, H. ;

Quinn, D. I. ;

Culine, S. ;

Sternberg, C. N. ;

Mai, Y. ;

Poehlein, C. H. ;

Perini, R. F. ;

Bajorin, D. F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1015-1026

[2] Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial [J].

Giannarini, Gianluca ;

Crestani, Alessandro ;

Ficarra, Vincenzo .

EUROPEAN UROLOGY, 2018, 74 (06) :840-841

[3] Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial [J].

Linares-Espinos, Estefania ;

Sanchez-Salas, Rafael .

EUROPEAN UROLOGY, 2019, 75 (01) :199-199

[4] Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study [J].

Necchi, Andrea ;

Anichini, Andrea ;

Raggi, Daniele ;

Briganti, Alberto ;

Massa, Simona ;

Luciano, Roberta ;

Colecchia, Maurizio ;

Giannatempo, Patrizia ;

Mortarini, Roberta ;

Bianchi, Marco ;

Fare, Elena ;

Monopoli, Francesco ;

Colombo, Renzo ;

Gallina, Andrea ;

Salonia, Andrea ;

Messina, Antonella ;

Ali, Siraj M. ;

Madison, Russell ;

Ross, Jeffrey S. ;

Chung, Jon H. ;

Salvioni, Roberto ;

Mariani, Luigi ;

Montorsi, Francesco .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34) :3353-+

[5] Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations [J].

Pal, Sumanta K. ;

Rosenberg, Jonathan E. ;

Hoffman-Censits, Jean H. ;

Berger, Raanan ;

Quinn, David I. ;

Galsky, Matthew D. ;

Wolf, Juergen ;

Dittrich, Christian ;

Keam, Bhumsuk ;

Delord, Jean-Pierre ;

Schellens, Jan H. M. ;

Gravis, Gwenaelle ;

Medioni, Jacques ;

Maroto, Pablo ;

Sriuranpong, Virote ;

Charoentum, Chaiyut ;

Burris, Howard A. ;

Grunwald, Viktor ;

Petrylak, Daniel ;

Vaishampayan, Ulka ;

Gez, Eliahu ;

De Giorgi, Ugo ;

Lee, Jae-Lyun ;

Voortman, Jens ;

Gupta, Sumati ;

Sharma, Sunil ;

Mortazavi, Amir ;

Vaughn, David J. ;

Isaacs, Randi ;

Parker, Katie ;

Chen, Xueying ;

Yu, Kun ;

Porter, Dale ;

Porta, Diana Graus ;

Bajorin, Dean F. .

CANCER DISCOVERY, 2018, 8 (07) :812-821

[6] Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial [J].

Parekh, Dipen J. ;

Reis, Isildinha M. ;

Castle, Erik P. ;

Gonzalgo, Mark L. ;

Woods, Michael E. ;

Svatek, Robert S. ;

Weizer, Alon Z. ;

Konety, Badrinath R. ;

Tollefson, Mathew ;

Krupski, Tracey L. ;

Smith, Norm D. ;

Shabsigh, Ahmad ;

Barocas, Daniel A. ;

Quek, Marcus L. ;

Dash, Atreya ;

Kibel, Adam S. ;

Shemanski, Lynn ;

Pruthi, Raj S. ;

Montgomery, Jeffrey Scott ;

Weight, Christopher J. ;

Sharp, David S. ;

Chang, Sam S. ;

Cookson, Michael S. ;

Gupta, Gopal N. ;

Gorbonos, Alex ;

Uchio, Edward M. ;

Skinner, Eila ;

Venkatramani, Vivek ;

Soodana-Prakash, Nachiketh ;

Kendrick, Kerri ;

Smith, Joseph A., Jr. ;

Thompson, Ian M. .

LANCET, 2018, 391 (10139) :2525-2536

[7] Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial [J].

Powles, Thomas ;

Duran, Ignacio ;

van der Heijden, Michiel S. ;

Loriot, Yohann ;

Vogelzang, Nicholas J. ;

De Giorgi, Ugo ;

Oudard, Stephane ;

Retz, Margitta M. ;

Castellano, Daniel ;

Bamias, Aristotelis ;

Flechon, Aude ;

Gravis, Gwenaelle ;

Hussain, Syed ;

Takano, Toshimi ;

Leng, Ning ;

Kadel, Edward E., III ;

Banchereau, Romain ;

Hegde, Priti S. ;

Mariathasan, Sanjeev ;

Cui, Na ;

Shen, Xiaodong ;

Derleth, Christina L. ;

Green, Marjorie C. ;

Ravaud, Alain .

LANCET, 2018, 391 (10122) :748-757

[8] Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer [J].

Robertson, A. Gordon ;

Kim, Jaegil ;

Al-Ahmadie, Hikmat ;

Bellmunt, Joaquim ;

Guo, Guangwu ;

Cherniack, Andrew D. ;

Hinoue, Toshinori ;

Laird, Peter W. ;

Hoadley, Katherine A. ;

Akbani, Rehan ;

Castro, Mauro A. A. ;

Gibb, Ewan A. ;

Kanchi, Rupa S. ;

Gordenin, Dmitry A. ;

Shukla, Sachet A. ;

Sanchez-Vega, Francisco ;

Hansel, Donna E. ;

Czerniak, Bogdan A. ;

Reuter, Victor E. ;

Su, Xiaoping ;

Carvalho, Benilton de Sa ;

Chagas, Vinicius S. ;

Mungall, Karen L. ;

Sadeghi, Sara ;

Pedamallu, Chandra Sekhar ;

Lu, Yiling ;

Klimczak, Leszek J. ;

Zhang, Jiexin ;

Choo, Caleb ;

Ojesina, Akinyemi I. ;

Bullman, Susan ;

Leraas, Kristen M. ;

Lichtenberg, Tara M. ;

Wu, Catherine J. ;

Schultz, Nicholaus ;

Getz, Gad ;

Meyerson, Matthew ;

Mills, Gordon B. ;

McConkey, David J. ;

Weinstein, John N. ;

Kwiatkowski, David J. ;

Lerner, Seth P. .

CELL, 2017, 171 (03) :540-+

[9] First results from the primary analysis population of the phase 2 study of erdafitinib (ERDA; JNJ-42756493) in patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) and FGFR alterations (FGFRalt). [J].

Siefker-Radtke, Arlene O. ;

Necchi, Andrea ;

Park, Se Hoon ;

GarcAa-Donas, JesAs ;

Huddart, Robert A. ;

Burgess, Earle Frederick ;

Fleming, Mark T. ;

Rezazadeh, Arash ;

Mellado, Begona ;

Varlamov, Sergei ;

Joshi, Monika ;

Duran, Ignacio ;

Tagawa, Scott T. ;

OHagan, Anne ;

Avadhani, Anjali Narayan ;

Zhong, Bob ;

De Porre, Peter ;

Loriot, Yohann .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[10] EMA and FDA prune the checkpoint inhibitor treatment landscape [J].

Teo, Min Yuen ;

Rosenberg, Jonathan E. .

NATURE REVIEWS UROLOGY, 2018, 15 (10) :595-597

← 1 →